Search Results 411-420 of 19782 for CLL

  1. Sickle cell anemia - Doctors and departments - Mayo Clinic

    Blood Cancers & Disorders Discussions. hikerny · Anyone have chronic lymphocytic leukemia (CLL)?. 196 Replies Tue, Apr 14, 2026.

  2. Clinical trials - Oncology (Medical)

    This phase II trials studies how well acalabrutinib with or without obinutuzumab works in treating participants with early-stage chronic lymphocytic leukemia or ...

  3. Clinical trials - Oncology (Medical)

    A Study of Hematopoiesis in Patients with Monoclonal B Cell Lymphocytosis (MBL), B-Chronic Lymphocytic Leukemia (CLL), and Healthy Controls. Rochester, Minn ...

  4. Hematology - Clinical trials

    A Study To Evaluate Acalabrutinib With Or Without Obinutuzumab To Treat Early-Stage Chronic Lymphocytic Leukemia Or Small Lymphocytic Lymphoma Patients.

  5. Rituximab and hyaluronidase human, recombinant (subcutaneous route) - Side effects & uses - Mayo Clinic

    ... chronic lymphocytic leukemia (CLL). It is also used together with other medicines to treat diffuse large B-cell lymphoma (DLBCL) in people who have not ...

  6. Living With Cancer: Myths and misunderstandings about the causes of cancer - Mayo Clinic News Network

    Complications include frequent infections, increased risk of other cancers and immune system problems. People with early stage chronic lymphocytic leukemia ...

  7. Zhiquan Wang, Ph.D. - Mayo Clinic Faculty Profiles

    Wang investigates how chromatin regulators sustain the leukemic processes that contribute to the biological capacity of chronic lymphocytic leukemia (CLL) cells ...

  8. Hematology - Clinical trials

    ... chronic lymphocytic leukemia (CLL). This study will also allow participants who are currently progressing on a Bruton tyrosine kinase inhibitor (BTKi) and ...

  9. Clinical trials - Oncology (Medical)

    A Study to Evaluate Acalabrutinib With or Without Obinutuzumab to Treat Early-Stage Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Patients.

  10. Clinical trials - Oncology (Medical)

    A Study to Evaluate Acalabrutinib With or Without Obinutuzumab to Treat Early-Stage Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Patients.